Diagnostic Centre, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Eur J Neurol. 2022 Jan;29(1):168-177. doi: 10.1111/ene.15110. Epub 2021 Sep 28.
The distribution of the major modifiable risk factors for intracerebral hemorrhage (ICH) changes rapidly. These changes call for contemporary data from large-scale population-based studies. The aim of the present study was to examine trends in incidence, risk factors, and mortality in ICH patients from 2004 to 2017.
In a population-based cohort study, we calculated age- and sex-standardized incidence rates (SIRs), incidence rates (IRs) stratified by age and sex per 100,000 person-years, and trends in risk profiles. We estimated absolute mortality risk, and the Cox proportional hazards regression multivariable-adjusted hazard ratios for 30-day and 1-year mortality.
We included 16,902 patients (53% men; median age 75 years) from 2004 to 2017. The SIR of ICH decreased from 33 (95% confidence interval [CI] 32-34) in 2004/2005 to 28 (95% CI 27-29) in 2016/2017. Among patients aged ≥70 years, the IR decreased from 137 (95% CI 130-144) in 2004/2005 to 112 (95% CI 106-117) in 2016/2017. The IR in patients aged <70 years was unchanged. From 2004 to 2017, the proportion of patients with hypertension increased from 49% to 66%, the use of oral anticoagulants increased from 7% to 18%, and the use of platelet inhibitors decreased from 40% to 28%. The adjusted hazard ratio for 30-day mortality in 2016/2017 was 0.94 (95% CI 0.89-1.01) and 1-year mortality was 0.98 (95% CI 0.93-1.04) compared with 2004/2005.
The incidence of spontaneous ICH decreased from 2004 to 2017, with no clear trend in mortality. The risk profile of ICH patients changed substantially, with increasing proportions of hypertension and anticoagulant treatment. Given the high mortality rate of ICH, further advances in prevention and treatment are urgently needed.
颅内出血(ICH)的主要可改变风险因素的分布迅速变化。这些变化需要来自大规模基于人群的研究的当代数据。本研究的目的是检查 2004 年至 2017 年 ICH 患者的发病率、风险因素和死亡率的趋势。
在一项基于人群的队列研究中,我们计算了年龄和性别标准化发病率(SIR)、每 100,000 人年按年龄和性别分层的发病率(IR)以及风险特征的趋势。我们估计了 30 天和 1 年死亡率的绝对死亡率风险和 Cox 比例风险回归多变量调整后的 30 天和 1 年死亡率风险比。
我们纳入了 2004 年至 2017 年的 16902 名患者(53%为男性;中位年龄 75 岁)。ICH 的 SIR 从 2004/2005 年的 33(95%置信区间 [CI] 32-34)降至 2016/2017 年的 28(95% CI 27-29)。在≥70 岁的患者中,IR 从 2004/2005 年的 137(95% CI 130-144)降至 2016/2017 年的 112(95% CI 106-117)。<70 岁患者的 IR 保持不变。从 2004 年到 2017 年,高血压患者的比例从 49%增加到 66%,口服抗凝剂的使用从 7%增加到 18%,血小板抑制剂的使用从 40%减少到 28%。与 2004/2005 年相比,2016/2017 年 30 天死亡率的调整后的危险比为 0.94(95%CI 0.89-1.01),1 年死亡率为 0.98(95%CI 0.93-1.04)。
自发性 ICH 的发病率从 2004 年到 2017 年下降,死亡率没有明显趋势。ICH 患者的风险状况发生了重大变化,高血压和抗凝治疗的比例增加。鉴于 ICH 的高死亡率,迫切需要在预防和治疗方面取得进一步进展。